Saturday, September 30, 2023
Courthouse News Service
Saturday, September 30, 2023 | Back issues
Courthouse News Service Courthouse News Service

Pharma Whistleblower

The Ninth Circuit on Thursday revived part of a man’s whistleblower claims against three pharmaceutical companies that he said promoted dangerous off-label uses of the heart drug Integrilin, so the trial court can determine if the whistleblower is an “original source” of the information.

SAN FRANCISCO – The Ninth Circuit on Thursday revived part of a man’s whistleblower claims against three pharmaceutical companies that he said promoted dangerous off-label uses of the heart drug Integrilin, so the trial court can determine if the whistleblower is an “original source” of the information.

Categories / Appeals, Business, Consumers

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.

Loading...